8-K current report · filed Jul 1, 2026

Bausch Health Companies Inc (BHC) 8-K Current Report: July 1, 2026

Item 5.02Item 7.01BHC overview

Short answer

Bausch Health Companies Inc (BHC) filed an 8-K current report with the SEC on July 1, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Michael Goettler resigning from Bausch Health’s Board effective June 30, 2026.

Bausch Health Companies Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Michael Goettler resigning from Bausch Health’s Board effective June 30, 2026
  • Departure tied to his appointment as President and CEO of Knoa Pharma LLC
  • No disagreement with Bausch Health’s operations, policies or practices reported
  • Board composition change without disclosed strategic or governance conflict

Item 7.01 · Regulation FD Disclosure

  • Press release announces Mr. Goettler’s resignation, signaling a senior leadership transition
  • Investor focus: successor appointment, timing, and potential strategy or execution impact

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Bausch Health Companies Inc 8-K filings

Get the next BHC 8-K as it lands

Follow BHC for push alerts, or ask the research agent what this filing means.